Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
about
Quantitative phenotyping-based in vivo chemical screening in a zebrafish model of leukemia stem cell xenotransplantationManganese superoxide dismutase in cancer prevention.Mitochondrial membrane potential and reactive oxygen species in cancer stem cells.Exposure of chronic myelogenous leukemia cells to imatinib results in the post-transcriptional induction of manganese superoxide dismutase.
P2860
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@en
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@nl
type
label
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@en
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@nl
prefLabel
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@en
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@nl
P2093
P2860
P1433
P1476
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy.
@en
P2093
Dandan Yin
Renan Chen
Siyong Huang
Yingmin Liang
P2860
P2888
P304
P356
10.1007/S12032-010-9529-9
P577
2010-04-21T00:00:00Z